Designs for adding a treatment arm to an ongoing clinical trial

door Bennett, Maxine, Mander, Adrian P.
Gepubliceerd in Trials (2020)

Escalation strategies for combination therapy Phase I trials

door Sweeting, Michael J, Mander, Adrian P
Gepubliceerd in 2012

Minimizing the Maximum Expected Sample Size in Two-Stage Phase II Clinical Trials with Continuous Outcomes

door Wason, James M. S., Mander, Adrian P.
Gepubliceerd in 2012

A product of independent beta probabilities dose escalation design for dual-agent phase I trials

door Mander, Adrian P, Sweeting, Michael J
Gepubliceerd in Stat Med (2015)

The choice of test in phase II cancer trials assessing continuous tumour shrinkage when complete responses are expected

door Wason, James MS, Mander, Adrian P
Gepubliceerd in Stat Methods Med Res (2015)

Do single‐arm trials have a role in drug development plans incorporating randomised trials?

door Grayling, Michael J., Mander, Adrian P.
Gepubliceerd in Pharm Stat (2015)

Re-formulating Gehan’s design as a flexible two-stage single-arm trial

door Grayling, Michael J., Mander, Adrian P.
Gepubliceerd in BMC Med Res Methodol (2019)

Calculations involving the multivariate normal and multivariate t distributions with and without truncation

door Grayling, Michael J., Mander, Adrian P.
Gepubliceerd in Stata J (2018)

Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?

door Wason, James M S, Stecher, Lynne, Mander, Adrian P
Gepubliceerd in 2014

Sample size re-estimation in crossover trials: application to the AIM HY-INFORM study

door Wych, Julie, Grayling, Michael J., Mander, Adrian P.
Gepubliceerd in Trials (2019)

A stochastically curtailed two-arm randomised phase II trial design for binary outcomes

door Law, Martin, Grayling, Michael J., Mander, Adrian P.
Gepubliceerd in Pharm Stat (2021)

A stochastically curtailed single-arm phase II trial design for binary outcomes

door Law, Martin, Grayling, Michael J., Mander, Adrian P.
Gepubliceerd in J Biopharm Stat (2022)

Optimal multistage designs for randomised clinical trials with continuous outcomes

door Wason, James MS, Mander, Adrian P, Thompson, Simon G
Gepubliceerd in 2012

AplusB: A Web Application for Investigating A + B Designs for Phase I Cancer Clinical Trials

door Wheeler, Graham M., Sweeting, Michael J., Mander, Adrian P.
Gepubliceerd in PLoS One (2016)

Stepped wedge cluster randomized controlled trial designs: a review of reporting quality and design features

door Grayling, Michael J., Wason, James M. S., Mander, Adrian P.
Gepubliceerd in Trials (2017)

Toxicity‐dependent feasibility bounds for the escalation with overdose control approach in phase I cancer trials

door Wheeler, Graham M., Sweeting, Michael J., Mander, Adrian P.
Gepubliceerd in Stat Med (2017)

Group sequential designs for stepped-wedge cluster randomised trials

door Grayling, Michael J, Wason, James MS, Mander, Adrian P
Gepubliceerd in Clin Trials (2017)

An optimised multi-arm multi-stage clinical trial design for unknown variance

door Grayling, Michael J., Wason, James M.S., Mander, Adrian P.
Gepubliceerd in Contemp Clin Trials (2018)

Blinded and unblinded sample size reestimation in crossover trials balanced for period

door Grayling, Michael J., Mander, Adrian P., Wason, James M. S.
Gepubliceerd in Biom J (2018)

Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials

door Grayling, Michael J., Mander, Adrian P., Wason, James M. S.
Gepubliceerd in Biom J (2018)